These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33000264)

  • 21. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
    Miyata Y; Sato T; Ito A
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells.
    Kim JH; Park B
    Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
    Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
    Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway.
    Kim MJ; Lee TH; Kim SH; Choi YJ; Heo J; Kim YH
    Int J Oncol; 2010 Nov; 37(5):1177-85. PubMed ID: 20878065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
    Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
    Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
    Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
    Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway.
    Yang Y; Ye Y; Qiu Q; Xiao Y; Huang M; Shi M; Liang L; Yang X; Xu H
    Int Immunopharmacol; 2016 Dec; 41():8-16. PubMed ID: 27816728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptolide Suppressed the Microglia Activation to Improve Spinal Cord Injury Through miR-96/IKKβ/NF-κB Pathway.
    Huang Y; Zhu N; Chen T; Chen W; Kong J; Zheng W; Ruan J
    Spine (Phila Pa 1976); 2019 Jun; 44(12):E707-E714. PubMed ID: 31150368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duck enteritis virus activates CaMKKβ-AMPK to trigger autophagy in duck embryo fibroblast cells via increased cytosolic calcium.
    Yin H; Zhao L; Wang Y; Li S; Huo H; Chen H
    Virol J; 2018 Aug; 15(1):120. PubMed ID: 30081955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of triptolide on the activity of TM3 Leydig cells and AMPK/Akt/mTOR pathway].
    Ye XY; Chen L
    Zhonghua Nan Ke Xue; 2019 Sep; 25(9):787-791. PubMed ID: 32233204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.
    Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS
    Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
    Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
    Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon.
    Liu Y; Song F; Wu WK; He M; Zhao L; Sun X; Li H; Jiang Y; Yang Y; Peng K
    Cell Biochem Funct; 2012 Jun; 30(4):271-8. PubMed ID: 22315045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis.
    Tan BJ; Chiu GN
    Int J Oncol; 2013 May; 42(5):1605-12. PubMed ID: 23467622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
    Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
    Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.